Prognostic Implications of Right Ventricular Function and Pulmonary Pressures Assessed by Echocardiography in Hospitalized Patients with COVID-19

Aims: Pulmonary involvement in Coronavirus disease 2019 (COVID-19) may affect right ventricular (RV) function and pulmonary pressures. The prognostic value of tricuspid annular plane systolic excursion (TAPSE), systolic pulmonary artery pressure (PAPS), and TAPSE/PAPS ratios have been poorly investigated in this clinical setting. Methods and results: This is a multicenter Italian study, including consecutive patients hospitalized for COVID-19. In-hospital mortality and pulmonary embolism (PE) were identified as the primary and secondary outcome measures, respectively. The study included 227 (16.1%) subjects (mean age 68 ± 13 years); intensive care unit (ICU) admission was reported in 32.2%. At competing risk analysis, after stratifying the population into tertiles, according to TAPSE, PAPS, and TAPSE/PAPS ratio values, patients in the lower TAPSE and TAPSE/PAPS tertiles, as well as those in the higher PAPS tertiles, showed a significantly higher incidence of death vs. the probability to be discharged during the hospitalization. At univariable logistic regression analysis, TAPSE, PAPS, and TAPSE/PAPS were significantly associated with a higher risk of death and PE, both in patients who were and were not admitted to ICU. At adjusted multivariable regression analysis, TAPSE, PAPS, and TAPSE/PAPS resulted in independently associated risk of in-hospital death (TAPSE: OR 0.85, CI 0.74–0.97; PAPS: OR 1.08, CI 1.03–1.13; TAPSE/PAPS: OR 0.02, CI 0.02 × 10−1–0.2) and PE (TAPSE: OR 0.7, CI 0.6–0.82; PAPS: OR 1.1, CI 1.05–1.14; TAPSE/PAPS: OR 0.02 × 10−1, CI 0.01 × 10−2–0.04). Conclusions: Echocardiographic evidence of RV systolic dysfunction, increased PAPS, and poor RV-arterial coupling may help to identify COVID-19 patients at higher risk of mortality and PE during hospitalization.

[1]  G. De Luca,et al.  COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives , 2021, Oxidative medicine and cellular longevity.

[2]  J. McMurray,et al.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.

[3]  G. Galasso,et al.  Clinical conditions and echocardiographic parameters associated with mortality in COVID‐19 , 2021, European journal of clinical investigation.

[4]  G. Galasso,et al.  Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect? , 2021, Cardiology and Therapy.

[5]  G. Galasso,et al.  Chronic Oral Anticoagulation and Clinical Outcome in Hospitalized COVID-19 Patients , 2021, Cardiovascular Drugs and Therapy.

[6]  G. Musumeci,et al.  Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study , 2021, Journal of cardiovascular pharmacology.

[7]  A. Silverio,et al.  Pre-admission atrial fibrillation in COVID-19 patients: Prevalence and clinical impact , 2021, European Journal of Internal Medicine.

[8]  G. Lip,et al.  Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19 , 2021, Journal of the American College of Cardiology.

[9]  R. Flores-Ramírez,et al.  Letter by Carrizales-Sepúlveda et al Regarding Article, “Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study” , 2021, Circulation.

[10]  G. De Luca,et al.  Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients , 2021, BMC Cardiovascular Disorders.

[11]  H. Karmouty-quintana,et al.  Mechanisms of Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS) , 2021, Frontiers in Molecular Biosciences.

[12]  G. Galasso,et al.  Pulmonary embolism in COVID-19 patients: Prevalence, predictors and clinical outcome. , 2020, Thrombosis research.

[13]  L. Shaw,et al.  Prognostic Utility of Right Ventricular Remodeling Over Conventional Risk Stratification in Patients With COVID-19 , 2020, Journal of the American College of Cardiology.

[14]  G. Pontone,et al.  Role of multimodality imaging in evaluation of cardiovascular involvement in COVID-19 , 2020, Trends in Cardiovascular Medicine.

[15]  A. Silverio,et al.  Clinical characteristics and prognosis of hospitalized COVID‐19 patients with incident sustained tachyarrhythmias: A multicenter observational study , 2020, European journal of clinical investigation.

[16]  R. Cocchia,et al.  Right Ventricular Function and Pulmonary Pressures as Independent Predictors of Survival in Patients With COVID-19 Pneumonia , 2020, JACC: Cardiovascular Imaging.

[17]  C. Lodigiani,et al.  Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study , 2020, Pharmacological Research.

[18]  E. Argulian,et al.  Right Ventricular Dilation in Hospitalized Patients With COVID-19 Infection , 2020, JACC: Cardiovascular Imaging.

[19]  Yu-Xuan Cai,et al.  Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID-19 , 2020, JACC: Cardiovascular Imaging.

[20]  Eun Ji Kim,et al.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.

[21]  D. Fischman,et al.  COVID-19 Complicated by Acute Pulmonary Embolism and Right-Sided Heart Failure , 2020, JACC: Case Reports.

[22]  G. Pontone,et al.  COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel , 2020, European heart journal cardiovascular Imaging.

[23]  Mohammad Madjid,et al.  Potential Effects of Coronaviruses on the Cardiovascular System: A Review. , 2020, JAMA cardiology.

[24]  Roberto Maroldi,et al.  Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). , 2020, JAMA cardiology.

[25]  A. Falanga,et al.  ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.

[26]  Ting Yu,et al.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.

[27]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[28]  Z. Memish,et al.  The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China , 2020, International Journal of Infectious Diseases.

[29]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): supplementary data , 2019 .

[30]  W. Seeger,et al.  Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension. , 2019, Circulation. Cardiovascular imaging.

[31]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) , 2019, European Respiratory Journal.

[32]  Kristian Thygesen,et al.  Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.

[33]  Yuchi Han,et al.  Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[34]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[35]  Simon Gibbs,et al.  [2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension]. , 2015, Kardiologia polska.

[36]  R. Arena,et al.  Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. , 2013, American journal of physiology. Heart and circulatory physiology.

[37]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[38]  C. Schneider,et al.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.